115 related articles for article (PubMed ID: 17178370)
1. Local toxicity of hepatic arterial infusion of hexokinase II inhibitor, 3-bromopyruvate: In vivo investigation in normal rabbit model.
Chang JM; Chung JW; Jae HJ; Eh H; Son KR; Lee KC; Park JH
Acad Radiol; 2007 Jan; 14(1):85-92. PubMed ID: 17178370
[TBL] [Abstract][Full Text] [Related]
2. Hepatic intra-arterial injection of 3-bromopyruvate in rabbit VX2 tumor.
Shin SW; Han H; Choo SW; Yoo BC; Park CK; Do YS; Lee JH; Lee DH; Choi D; Choo IW; Kim SS; Lee JY
Acta Radiol; 2006 Dec; 47(10):1036-41. PubMed ID: 17135005
[TBL] [Abstract][Full Text] [Related]
3. Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer.
Vali M; Liapi E; Kowalski J; Hong K; Khwaja A; Torbenson MS; Georgiades C; Geschwind JF
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):95-101. PubMed ID: 17296709
[TBL] [Abstract][Full Text] [Related]
4. [Effects of intra-arterial infusion of 3-bromopyruvate on metastases and survival benefit of hepatic VX2 tumor in rabbits].
Jiang XY; Zhang XP; Huang JH; Luo RG; Miao BJ; Wang Y
Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(39):3139-42. PubMed ID: 24417996
[TBL] [Abstract][Full Text] [Related]
5. Systemic administration of 3-bromopyruvate in treating disseminated aggressive lymphoma.
Schaefer NG; Geschwind JF; Engles J; Buchanan JW; Wahl RL
Transl Res; 2012 Jan; 159(1):51-7. PubMed ID: 22153810
[TBL] [Abstract][Full Text] [Related]
6. The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate: in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model.
Jae HJ; Chung JW; Park HS; Lee MJ; Lee KC; Kim HC; Yoon JH; Chung H; Park JH
Korean J Radiol; 2009; 10(6):596-603. PubMed ID: 19885316
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET for evaluating the antitumor effect of intraarterial 3-bromopyruvate administration in a rabbit VX2 liver tumor model.
Park HS; Chung JW; Jae HJ; Kim YI; Son KR; Lee MJ; Park JH; Kang WJ; Yoon JH; Chung H; Lee K
Korean J Radiol; 2007; 8(3):216-24. PubMed ID: 17554189
[TBL] [Abstract][Full Text] [Related]
8. Assessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor.
Liapi E; Geschwind JF; Vali M; Khwaja AA; Prieto-Ventura V; Buijs M; Vossen JA; Ganapathy-Kanniappan S; Wahl RL
J Nucl Med; 2011 Feb; 52(2):225-30. PubMed ID: 21233194
[TBL] [Abstract][Full Text] [Related]
9. Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study.
Vali M; Vossen JA; Buijs M; Engles JM; Liapi E; Ventura VP; Khwaja A; Acha-Ngwodo O; Ganapathy-Kanniappan S; Syed L; Wahl RL; Geschwind JF
J Pharmacol Exp Ther; 2008 Oct; 327(1):32-7. PubMed ID: 18591216
[TBL] [Abstract][Full Text] [Related]
10. Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization.
Vossen JA; Buijs M; Syed L; Kutiyanwala F; Kutiyanwala M; Geschwind JF; Vali M
Clin Exp Metastasis; 2008; 25(7):811-7. PubMed ID: 18649116
[TBL] [Abstract][Full Text] [Related]
11. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.
Geschwind JF; Ko YH; Torbenson MS; Magee C; Pedersen PL
Cancer Res; 2002 Jul; 62(14):3909-13. PubMed ID: 12124317
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic advantage of intra-arterial cyclosporin A delivery to vascularly isolated rabbit forelimb. I. Model development.
Shirbacheh MV; Ren X; Jones JW; Breidenbach WC; Jevans AW; Fernandez-Botran GR; Maldonado C; Barker JH; Gruber SA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1185-90. PubMed ID: 10336504
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate.
Pereira da Silva AP; El-Bacha T; Kyaw N; dos Santos RS; da-Silva WS; Almeida FC; Da Poian AT; Galina A
Biochem J; 2009 Feb; 417(3):717-26. PubMed ID: 18945211
[TBL] [Abstract][Full Text] [Related]
14. [Tumor proliferation and apoptosis after preoperative hepatic and regional arterial infusion chemotherapy in prevention of liver metastasis after colorectal cancer surgery].
Zhong YS; Lü SX; Xu JM
Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(16):1229-33. PubMed ID: 19094597
[TBL] [Abstract][Full Text] [Related]
15. [Plasma platinum concentration and anti-tumor effects after intra-arterial infusion of lipiodol-CDDP suspension evaluation with VX 2 rabbit liver cancer model and 7.0 Tesla MRI system].
Sonoda A; Nitta N; Ohta S; Itoh R; Takahashi M; Murata K; Morikawa S; Inubushi T; Miyagawa Y; Takamori M; Oonaka Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):951-7. PubMed ID: 16835486
[TBL] [Abstract][Full Text] [Related]
16. 3-Bromopyruvic acid, a hexokinase II inhibitor, is an effective antitumor agent on the hepatoma cells : in vitro and in vivo findings.
Gong L; Wei Y; Yu X; Peng J; Leng X
Anticancer Agents Med Chem; 2014 Jun; 14(5):771-6. PubMed ID: 24738957
[TBL] [Abstract][Full Text] [Related]
17. The influence of intraarterial high-dose cisplatin with concomitant irradiation on arterial microanastomosis: an experimental study.
Wang ZH; Zhang SZ; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
Am J Clin Oncol; 2009 Apr; 32(2):158-62. PubMed ID: 19307956
[TBL] [Abstract][Full Text] [Related]
18. [Effects of intermittent and continuous thermochemotherapeutic intra artery infusion on adriamycin concentration in rabbit VX-2 tumor].
Zhang HX; Liu Y; He XL; Liu YY; Cao W; Wei J; Ni DH; Li WX; Han RY
Ai Zheng; 2004 Apr; 23(4):372-5. PubMed ID: 15087021
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor.
Cao X; Bloomston M; Zhang T; Frankel WL; Jia G; Wang B; Hall NC; Koch RM; Cheng H; Knopp MV; Sun D
Clin Cancer Res; 2008 Mar; 14(6):1831-9. PubMed ID: 18347186
[TBL] [Abstract][Full Text] [Related]
20. A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates.
Mancini R; Carpanese L; Sciuto R; Pizzi G; Golfieri R; Giampalma L; Cappelli A; Galaverni MC; Blotta A; Fiore F; Izzo F; Lastoria S; Mastro A; Di Marzo M; Cagol PP; Gasparini D; Geatti O; Bacchetti S; Pasqual E; Zeuli M; Paoletti G; Garufi C; Cosimelli M;
In Vivo; 2006; 20(6A):711-4. PubMed ID: 17203751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
